Cargando…

Assessing chemotherapy dosing strategies in a spatial cell culture model

Predicting patient responses to chemotherapy regimens is a major challenge in cancer treatment. Experimental model systems coupled with quantitative mathematical models to calculate optimal dose and frequency of drugs can enable improved chemotherapy regimens. Here we developed a simple approach to...

Descripción completa

Detalles Bibliográficos
Autores principales: Deb, Dhruba, Zhu, Shu, LeBlanc, Michael J., Danino, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729937/
https://www.ncbi.nlm.nih.gov/pubmed/36505801
http://dx.doi.org/10.3389/fonc.2022.980770
_version_ 1784845571814588416
author Deb, Dhruba
Zhu, Shu
LeBlanc, Michael J.
Danino, Tal
author_facet Deb, Dhruba
Zhu, Shu
LeBlanc, Michael J.
Danino, Tal
author_sort Deb, Dhruba
collection PubMed
description Predicting patient responses to chemotherapy regimens is a major challenge in cancer treatment. Experimental model systems coupled with quantitative mathematical models to calculate optimal dose and frequency of drugs can enable improved chemotherapy regimens. Here we developed a simple approach to track two-dimensional cell colonies composed of chemo-sensitive and resistant cell populations via fluorescence microscopy and coupled this to computational model predictions. Specifically, we first developed multiple 4T1 breast cancer cell lines resistant to varying concentrations of doxorubicin, and demonstrated how heterogeneous populations expand in a two-dimensional colony. We subjected cell populations to varied dose and frequency of chemotherapy and measured colony growth. We then built a mathematical model to describe the dynamics of both chemosensitive and chemoresistant populations, where we determined which number of doses can produce the smallest tumor size based on parameters in the system. Finally, using an in vitro model we demonstrated multiple doses can decrease overall colony growth as compared to a single dose at the same total dose. In the future, this system can be adapted to optimize dosing strategies in the setting of heterogeneous cell types or patient derived cells with varied chemoresistance.
format Online
Article
Text
id pubmed-9729937
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97299372022-12-09 Assessing chemotherapy dosing strategies in a spatial cell culture model Deb, Dhruba Zhu, Shu LeBlanc, Michael J. Danino, Tal Front Oncol Oncology Predicting patient responses to chemotherapy regimens is a major challenge in cancer treatment. Experimental model systems coupled with quantitative mathematical models to calculate optimal dose and frequency of drugs can enable improved chemotherapy regimens. Here we developed a simple approach to track two-dimensional cell colonies composed of chemo-sensitive and resistant cell populations via fluorescence microscopy and coupled this to computational model predictions. Specifically, we first developed multiple 4T1 breast cancer cell lines resistant to varying concentrations of doxorubicin, and demonstrated how heterogeneous populations expand in a two-dimensional colony. We subjected cell populations to varied dose and frequency of chemotherapy and measured colony growth. We then built a mathematical model to describe the dynamics of both chemosensitive and chemoresistant populations, where we determined which number of doses can produce the smallest tumor size based on parameters in the system. Finally, using an in vitro model we demonstrated multiple doses can decrease overall colony growth as compared to a single dose at the same total dose. In the future, this system can be adapted to optimize dosing strategies in the setting of heterogeneous cell types or patient derived cells with varied chemoresistance. Frontiers Media S.A. 2022-11-24 /pmc/articles/PMC9729937/ /pubmed/36505801 http://dx.doi.org/10.3389/fonc.2022.980770 Text en Copyright © 2022 Deb, Zhu, LeBlanc and Danino https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Deb, Dhruba
Zhu, Shu
LeBlanc, Michael J.
Danino, Tal
Assessing chemotherapy dosing strategies in a spatial cell culture model
title Assessing chemotherapy dosing strategies in a spatial cell culture model
title_full Assessing chemotherapy dosing strategies in a spatial cell culture model
title_fullStr Assessing chemotherapy dosing strategies in a spatial cell culture model
title_full_unstemmed Assessing chemotherapy dosing strategies in a spatial cell culture model
title_short Assessing chemotherapy dosing strategies in a spatial cell culture model
title_sort assessing chemotherapy dosing strategies in a spatial cell culture model
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729937/
https://www.ncbi.nlm.nih.gov/pubmed/36505801
http://dx.doi.org/10.3389/fonc.2022.980770
work_keys_str_mv AT debdhruba assessingchemotherapydosingstrategiesinaspatialcellculturemodel
AT zhushu assessingchemotherapydosingstrategiesinaspatialcellculturemodel
AT leblancmichaelj assessingchemotherapydosingstrategiesinaspatialcellculturemodel
AT daninotal assessingchemotherapydosingstrategiesinaspatialcellculturemodel